Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, ...
The Company further announced that the Audit Committee of the Board approved the engagement of Zhonghua as the Company’s independent auditor effective December 31, 2025. The change was not made due to ...
BEIJING--(BUSINESS WIRE)-- Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel ...
Feb.10 -- Hong Kong Food and Health Secretary Sophia Chan discusses the government's Covid-19 vaccination rollout plan and the efforts to fight the pandemic. She speaks with Rishaad Salamat and ...